treatment approaches for patients with tp53-mutated mcl
Published 8 months ago • 557 plays • Length 3:56Download video MP4
Download video MP3
Similar videos
-
2:42
challenges in treating patients with tp53-mutated mcl & promising novel therapies being explored
-
1:27
tp53-aberrant mcl: challenges and treatment approaches
-
1:27
treatment options for patients with tp53-mutated aml
-
2:23
improving treatment for patients with tp53-mutated myeloid malignancies
-
1:36
the impact of tp53 mutation on treatment approaches in mcl
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
8:14
progress in the treatment of tp53 mutated aml
-
1:19
treatment recommendations for patients with cll with del(17p) and tp53 aberrations
-
1:38
the importance of targeting tp53 in aml and agents being explored
-
1:08
novel strategies to target p53-mutant hematological malignancies
-
2:16
treating tp53 mutant mantle cell lymphoma in the boven trial
-
1:10
car-t therapy for high-risk mcl patients
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
0:44
unmet needs in aml: tp53 mutations and maintenance therapy
-
4:31
a risk-adapted treatment approach for mantle cell lymphoma
-
1:43
the role of targeted therapies in the frontline treatment of mantle cell lymphoma
-
1:49
dr. shah on treatment of patients with p53-mutated mcl
-
2:48
outcomes of autosct, allosct & car-t cell therapy in patients with tp53-altered mcl
-
5:04
the role of tp53 & ctdna kinetics in patients with r/r lbcl treated with glofitamab monotherapy